NO20040177L - Karbamatforbindelser for bruk til forebyggelse eller behandling av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte - Google Patents

Karbamatforbindelser for bruk til forebyggelse eller behandling av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte

Info

Publication number
NO20040177L
NO20040177L NO20040177A NO20040177A NO20040177L NO 20040177 L NO20040177 L NO 20040177L NO 20040177 A NO20040177 A NO 20040177A NO 20040177 A NO20040177 A NO 20040177A NO 20040177 L NO20040177 L NO 20040177L
Authority
NO
Norway
Prior art keywords
pain
cluster
prevention
treatment
migraine headache
Prior art date
Application number
NO20040177A
Other languages
English (en)
Norwegian (no)
Inventor
Ellen C Codd
Carlos R Plata-Salaman
Boyu Zhao
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20040177L publication Critical patent/NO20040177L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20040177A 2001-07-16 2004-01-15 Karbamatforbindelser for bruk til forebyggelse eller behandling av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte NO20040177L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30568701P 2001-07-16 2001-07-16
PCT/US2002/021787 WO2003007936A1 (en) 2001-07-16 2002-07-11 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
US10/192,973 US20030069306A1 (en) 2001-07-16 2002-07-11 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Publications (1)

Publication Number Publication Date
NO20040177L true NO20040177L (no) 2004-03-16

Family

ID=26888550

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040177A NO20040177L (no) 2001-07-16 2004-01-15 Karbamatforbindelser for bruk til forebyggelse eller behandling av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte

Country Status (22)

Country Link
US (3) US20030069306A1 (sr)
EP (1) EP1406606B1 (sr)
JP (1) JP4362368B2 (sr)
KR (1) KR100995936B1 (sr)
CN (2) CN101669933A (sr)
AU (1) AU2002354909B2 (sr)
BR (1) BR0211240A (sr)
CA (1) CA2454047C (sr)
CY (1) CY1106038T1 (sr)
DE (1) DE60217493T2 (sr)
DK (1) DK1406606T3 (sr)
ES (1) ES2278035T3 (sr)
HU (1) HUP0401110A3 (sr)
IL (1) IL159846A0 (sr)
MX (1) MXPA04000555A (sr)
NO (1) NO20040177L (sr)
NZ (1) NZ549751A (sr)
PL (1) PL368112A1 (sr)
PT (1) PT1406606E (sr)
RS (1) RS50946B (sr)
RU (1) RU2299729C2 (sr)
WO (1) WO2003007936A1 (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0523550D0 (en) 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
KR102489052B1 (ko) * 2016-05-19 2023-01-16 에스케이바이오팜 주식회사 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103A (en) * 1849-02-06 Camphene-lamp
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
IL112134A (en) * 1993-12-29 1999-12-22 Merck Sharp & Dohme Substituted morpholine derivatives their preparation and pharmaceutical compositions containing them
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
AU7349301A (en) * 2000-07-21 2002-02-05 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
HK1063288A1 (en) 2004-12-24
CY1106038T1 (el) 2011-04-06
AU2002354909B2 (en) 2006-10-05
NZ549751A (en) 2008-04-30
CN101669933A (zh) 2010-03-17
RU2299729C2 (ru) 2007-05-27
CA2454047A1 (en) 2003-01-30
RS4504A (sr) 2006-12-15
CA2454047C (en) 2011-06-21
JP4362368B2 (ja) 2009-11-11
US20050009905A1 (en) 2005-01-13
CN1592617A (zh) 2005-03-09
WO2003007936A1 (en) 2003-01-30
PT1406606E (pt) 2007-03-30
PL368112A1 (en) 2005-03-21
DK1406606T3 (da) 2007-03-05
KR100995936B1 (ko) 2010-11-22
MXPA04000555A (es) 2005-06-20
BR0211240A (pt) 2004-07-27
KR20040016993A (ko) 2004-02-25
EP1406606B1 (en) 2007-01-10
HUP0401110A2 (hu) 2004-09-28
RS50946B (sr) 2010-08-31
DE60217493T2 (de) 2007-11-15
HUP0401110A3 (en) 2012-09-28
DE60217493D1 (de) 2007-02-22
JP2004536856A (ja) 2004-12-09
US20060293383A1 (en) 2006-12-28
IL159846A0 (en) 2004-06-20
EP1406606A1 (en) 2004-04-14
RU2004100965A (ru) 2005-02-20
US20030069306A1 (en) 2003-04-10
WO2003007936A8 (en) 2004-10-14
ES2278035T3 (es) 2007-08-01

Similar Documents

Publication Publication Date Title
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
NO20044195L (no) Biofosfoninsyrer for behandling og prevensjon av osteoprose
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
IS7189A (is) Sómatóstatín- eða bombesínhliðstæðusamstæður til greiningar eða meðferðar og notkun þeirra
EE200200145A (et) Retigabiini kasutamine neuropaatilise valu raviks
NO20025307D0 (no) Anvendelse av IL-18 inhibitorer til behandling og/eller forebygging av aterosklerose
HUP0400119A3 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
NO20033803L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bevegelseslidelser
NO20033443D0 (no) Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser
IS8004A (is) Aðferð við meðhöndlun á vægri vitsmunaskerðingu og til að fyrirbyggja eða tefja Alzheimers-sjúkdóminn
NO20034300D0 (no) Nye cyano-substituerte dihydropyrimidinforbindelser og anvendelse for behandling av sykdommer
NO20054913D0 (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
ITTO20010848A0 (it) Disposizione e metodo di purificazione o trattamento elettrochimico.
NO20033228D0 (no) Anvendelse av IL-18 inhibitorer til behandling og/eller forhindring av hjertesykdom
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
NO20033801D0 (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
NO20040177L (no) Karbamatforbindelser for bruk til forebyggelse eller behandling av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
NO20040935L (no) Plaster for behandling av dysfunksjoner og forstyrrelser i negler.
RU2003102874A (ru) Способ профилактики и/или лечения дыхательной системы
SI1610785T1 (sl) Farmacevtski kombiniran pripravek za zdravljenje spastiäśnosti in/ali boleäśine
SI1569929T1 (sl) Spojine in postopki za zdravljenje ali preprečevanje flavivirusnih infekcij
GB0219706D0 (en) The treatment of neuropathic pain
ITBO20030320A1 (it) Metodo ed impianto per il trattamento della cellulite e/o della massa grassa.
NO20051879D0 (no) Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft
ITBO20020343A0 (it) Metodo ed impianto per il trattamento di pasta alimentare

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application